<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2016.3410</article-id>
<article-id pub-id-type="publisher-id">ETM-0-0-3410</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Protective effect of naringin against ankylosing spondylitis via ossification, inflammation and oxidative stress in mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Liu</surname><given-names>Kang</given-names></name>
<xref rid="af1-etm-0-0-3410" ref-type="aff"/></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Lianguo</given-names></name>
<xref rid="af1-etm-0-0-3410" ref-type="aff"/>
<xref rid="c1-etm-0-0-3410" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Shi</surname><given-names>Xiaolin</given-names></name>
<xref rid="af1-etm-0-0-3410" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Wu</surname><given-names>Fengqing</given-names></name>
<xref rid="af1-etm-0-0-3410" ref-type="aff"/></contrib>
</contrib-group>
<aff id="af1-etm-0-0-3410">Department of Orthopedics, The Second Hospital Affiliated to Zhejiang University of Chinese Medicine, Hangzhou, Zhejiang 310005, P.R. China</aff>
<author-notes>
<corresp id="c1-etm-0-0-3410"><italic>Correspondence to</italic>: Mr. Lianguo Wu, Department of Orthopedics, The Second Hospital Affiliated to Zhejiang University of Chinese Medicine, 318 Chaowang Road, Hangzhou, Zhejiang 310005, P.R. China, E-mail: <email>lianguowudl@163.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>08</month>
<year>2016</year></pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>05</month>
<year>2016</year></pub-date>
<volume>12</volume>
<issue>2</issue>
<fpage>1153</fpage>
<lpage>1158</lpage>
<history>
<date date-type="received"><day>16</day><month>12</month><year>2014</year></date>
<date date-type="accepted"><day>04</day><month>02</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2016, Spandidos Publications</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Naringin is an abundant flavanone in pomelo, grapefruit as well as lime and its variants, has been shown to exhibit certain antioxidative, anti-inflammatory, anti-cancer and hypoglycemic effects. The aim of the current study was to evaluate the protective effects of naringin against ankylosing spondylitis (AS) and to elucidate the potential underlying mechanism. Firstly, a mouse model of ankylosing spondylitis (AS) was established. Next, osteocalcin (OC), alkaline phosphatase (ALP) and triglyceride (TG) activity values, inflammatory factor and oxidative stress were evaluated in the AS mice. Then, the Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) protein expression levels in the AS mice were investigated using western blot analysis. The results showed that naringin increased OC, ALP and TG activity values in the AS mouse model. Furthermore, inflammatory factor and oxidative stress levels in the AS mice were restrained by treatment with naringin. Furthermore, JAK2 and STAT3 protein expression levels were reduced by treatment with naringin. In conclusion, the present results indicated that the protective effects of naringin against AS are exerted via the induction of ossification, suppression of inflammation and oxidative stress and the downregulation of JAK2/STAT3 in mice.</p>
</abstract>
<kwd-group>
<kwd>naringin</kwd>
<kwd>ankylosing spondylitis</kwd>
<kwd>ossification</kwd>
<kwd>inflammation</kwd>
<kwd>oxidative stress</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Ankylosing spondylitis (AS) is an autoimmune disease characterized by sacroiliitis and spinal rigidity, which attack the axial joints (<xref rid="b1-etm-0-0-3410" ref-type="bibr">1</xref>). Clinical symptoms include the pain in areas including the lumbar, back, shoulder and neck, with or without spasticity. Furthermore, these can include heel pain, pain aggravation at night, even nocturnal awakening, turning difficult and obvious spasticity on waist in the early morning or after sedentary state (<xref rid="b2-etm-0-0-3410" ref-type="bibr">2</xref>). AS is a systemic autoimmune disease, with final outcomes including ossification of the ligaments around the spine and intervertebral disk, and the fibrosis of axial joints and bony ankylosis, leading to the disability of joint movement (<xref rid="b3-etm-0-0-3410" ref-type="bibr">3</xref>). Therefore, as pathological osteogenesis is the predominant cause of disability in AS patients, the treatment of AS may need to address the rigidity problems in normal ligament and synovial ossification (<xref rid="b4-etm-0-0-3410" ref-type="bibr">4</xref>).</p>
<p>Thrombocytosis may also occur in AS patients, which is known as reactive thrombocytosis (<xref rid="b5-etm-0-0-3410" ref-type="bibr">5</xref>). Thrombocytosis is also an inflammatory process, the interactions of various cytokines result in megakaryocytic hyperplasia, leading to an increase in platelet count and platelet-large cell ratio (<xref rid="b6-etm-0-0-3410" ref-type="bibr">6</xref>). However, in a clinical context, the inhibition of platelets in patients with AS is lower compared with that of rheumatoid arthritis (<xref rid="b7-etm-0-0-3410" ref-type="bibr">7</xref>).</p>
<p>Reactive oxygen species and reactive nitrogen species are harmful free radicals generated by metabolic processes, which can induce oxidative stress (<xref rid="b8-etm-0-0-3410" ref-type="bibr">8</xref>). Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-PX) are key antioxidant enzymes; SOD can remove superoxide radicals from biological cells by disproportionation, generating H<sub>2</sub>O<sub>2</sub> and O<sub>2</sub>, and H<sub>2</sub>O<sub>2</sub> may be catalyzed by CAT to generate H<sub>2</sub>O and O<sub>2</sub>, thereby reducing the toxicity of free radicals on the organism (<xref rid="b9-etm-0-0-3410" ref-type="bibr">9</xref>).</p>
<p>Naringin is (full name, naringenin-7-O-neohesperidin glycoside) is a dihydrogen flavonoid, and the primary active ingredient of a number of traditional Chinese medicines, including orange, <italic>Drynaria</italic> and <italic>Citrus aurantium</italic>. Naringin exhibits a wide range of biological activities, including anti-oxidation (<xref rid="b10-etm-0-0-3410" ref-type="bibr">10</xref>), bone growth promotion (<xref rid="b11-etm-0-0-3410" ref-type="bibr">11</xref>), plasma cholesterol reduction (<xref rid="b12-etm-0-0-3410" ref-type="bibr">12</xref>), anti-atherosclerotic (<xref rid="b13-etm-0-0-3410" ref-type="bibr">13</xref>), sedative (<xref rid="b14-etm-0-0-3410" ref-type="bibr">14</xref>), anti-tumor (<xref rid="b15-etm-0-0-3410" ref-type="bibr">15</xref>) and anti-fungal (<xref rid="b16-etm-0-0-3410" ref-type="bibr">16</xref>) properties. However, the protective effect of naringin against AS and the underlying molecular mechanism, including the signal pathways affecting ossification, inflammation and oxidative stress, remain unclear. The present study aimed to evaluate the protective effect of naringin against ossification, inflammation and oxidative stress, and to further investigate the possible underlying mechanisms, including anti-inflammatory signaling pathways.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Materials and chemicals</title>
<p>Osteocalcin (OC; ml026391), alkaline phosphatase (ALP; E-CL-M0075c) and triglyceride (TG; E-EL-M2603c), nuclear factor (NF)-&#x03BA;B p65 unit (ml026326), tumor necrosis factor-&#x03B1; (TNF-&#x03B1;; ml022566), interleukin-1&#x03B2; (IL-1&#x03B2;; ml028611), IL-6 (ml028608), malonaldehyde (MDA; ml027131), SOD (ml026976), CAT (E-EL-H5408c) and GSH-PX (E-EL-H5410c) enzyme-linked immunosorbent assay (ELISA) determination kits were obtained from the Beyotime Institute of Biotechnology (Nanjing, China). A bicinchoninic acid (BCA; 5000001) assay kit was obtained from Bio-Rad Laboratories, Inc. (Hercules, CA, USA). Naringin (purity, &#x003E;95&#x0025;) was purchased from Sigma-Aldrich (Sigma-Aldrich). The chemical structure of naringin is shown in <xref rid="f1-etm-0-0-3410" ref-type="fig">Fig. 1</xref>.</p>
</sec>
<sec>
<title>Construction of AS mouse model</title>
<p>All animal studies were performed in accordance with the regulations of the Zhejiang University Hospital for the care and use of laboratory animals (Shandong, China). Kunming mice were obtained from the Laboratory Animal Institute of The Second Hospital Affiliated to Zhejiang University of Chinese Medicine (Hangzhou, China). The AS model was established in the mice as described previously (<xref rid="b17-etm-0-0-3410" ref-type="bibr">17</xref>). A total of 50 mice were injected with 30 UI human chorionic gonadotropin hormone (HCG; Sigma-Aldrich) to induce superovulation. Then, zygotes were gathered and a HLAB2704 gene fragment was injected using microinjection into the pronucleus. Surviving zygotes were transferred into pseudocyesis mice for generation. In brief, AS model mice were prepared by Biocytogen Biological Technology Co. Ltd. (eijing, China). A total of 50 mice were injected with HCG hormone to induce superovulation. Next, ovum and sperm were integrated, zygotes were gathered and HLAB2704 gene fragments were injected using a microinjection into the pronucleus. Surviving zygotes were transferred into pseudocyesis mice for generation. The mice were sacrificed by incision under 50 mg/kg of sodium pentobarbital.</p>
</sec>
<sec>
<title>Grouping and treatment</title>
<p>Five treatment groups were established for the study (n=10 per group), as follows: i) Control group, which included normal mice that received 0.1 ml/100 g sodium pentobarbital (Sigma-Aldrich) injected intraperitoneally (i.p.); ii) AS group, which included AS mice that received 0.1 ml/100 g sodium pentobarbital (i.p.); iii) Nar (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>) group, which included AS mice that received 20 mg/kg naringin (i.p.) for 8 days (<xref rid="b18-etm-0-0-3410" ref-type="bibr">18</xref>); iv) Nar (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>) group, which included AS mice that received 40 mg/kg naringin (i.p.) for 8 days; and v) Nar (80), which included AS mice that received 80 mg/kg naringin (i.p.) for 8 days.</p>
</sec>
<sec>
<title>ELISA of OC, ALP and TG activity</title>
<p>Following treatment with naringin for 3 days, OC, ALP and TG, NF-&#x03BA;B p65 unit, TNF-&#x03B1;, IL-1&#x03B2; and IL-6, (inflammatory factors); MDA, SOD, CAT and activity of GSH-PX (oxidative stress) activity were determined using ELISA determination kits, according to the standard curve (Beyotime Institute of Biotechnology, China (Liu, Fan). The optical density was read at 405 nm using a Bio-Rad microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA).</p>
</sec>
<sec>
<title>Western blot analysis of signal transducer and activator of transcription 3 (STAT3) and Janus kinase 2 (JAK2) protein expressions in AS mouse model</title>
<p>After the treatment with naringin for 3 days, 10 mg AS tissue samples were removed, and incubated with 100 &#x00B5;l tissue lysis buffer (Thomas Scientific, Swedesboro, NJ, USA) for 30 min on ice. The protein concentration was measured using a BCA kit (Bio-Rad Laboratories, Inc.). Equal quantities of protein (50 &#x00B5;g) were resolved using 12&#x0025; SDS-polyacrylamide gel and transferred onto a polyvinylidene fluoride membrane (Bio-Rad Laboratories, Inc). Next, the membrane was blocked with 5&#x0025; non-fat milk and incubated with anti-p-STAT3 (sc-135649; 1:2,000), anti-p-JAK2 (sc-16566-R; 1: 3,000) and &#x03B2;-actin (sc-130657; 1:5,000; all purchased from Santa Cruz Biotechnology, Inc., Dallas, TX, USA) and incubated overnight at 4&#x00B0;C followed by incubation with an anti-rabbit secondary antibody (sc-2795; 1:5,000, Santa Cruz Biotechnology Inc.) for 30 min at 37&#x00B0;C. The signal was developed using an EasyBlot ECL kit (Shanghai Sangon Biological Engineering Technology &#x0026; Services Co., Ltd., Shanghai, China) according to the manufacturer&#x0027;s instructions. Densitometric measurement of the band intensity was performed with Quantity One software, version 4.4.0 (Bio-Rad Laboratories, Inc.).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Values were expressed as the mean &#x00B1; standard deviation and analysed using SPSS version 19.0, IBM SPSS, Inc., Chicago, IL, USA. One-way analysis of variance was performed for the statistical analysis of data using GraphPad Prism 5 software (GraphPad Software, San Diego, CA, USA). The Student&#x0027;s t-test was used to analyze statistical significance. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Effect of naringin on OC, ALP and TG activity in AS mouse model</title>
<p>To determine the protective effect of naringin on ossification in the AS mouse model, the activity OC, ALP and TG were evaluated. OC and ALP activity were found to be decreased, while the TG activity was enhanced in the AS mouse compared with the control (<xref rid="f2-etm-0-0-3410" ref-type="fig">Fig. 2</xref>). Pretreatment with naringin (20, 40 and 80 mg/kg) markedly altered the OC and ALP activity, and reduced the TG activity in the AS mice (<xref rid="f2-etm-0-0-3410" ref-type="fig">Fig. 2</xref>).</p>
</sec>
<sec>
<title>Effect of naringin on inflammatory factor expression in AS model mice</title>
<p>To determined the protective effect of naringin against the expression of inflammatory factors in the AS mouse model, the activity NF-&#x03BA;B p65 unit, TNF-&#x03B1;, IL-1&#x03B2; and IL-6 values were measured. As shown in <xref rid="f3-etm-0-0-3410" ref-type="fig">Fig. 3</xref>, NF-&#x03BA;B p65 unit, TNF-&#x03B1;, IL-1&#x03B2; and IL-6 activity values were increased in the AS mouse group compared with the control. When pretreated with naringin (20, 40 and 80 mg/kg) for 8 days, NF-&#x03BA;B p65 unit, TNF-&#x03B1;, IL-1&#x03B2; and IL-6 activity values were notably attenuated in the AS mice (<xref rid="f3-etm-0-0-3410" ref-type="fig">Fig. 3</xref>).</p>
</sec>
<sec>
<title>Effect of naringin on markers of oxidative stress in AS mouse model</title>
<p>To infer the protective effect of naringin on oxidative stress of AS mouse model, the activity of MDA, SOD, CAT and GSH-PX were evaluated. In the AS group, the MDA activity was elevated, while the SOD, CAT and GSH-PX activities were reduced compared with the control (<xref rid="f4-etm-0-0-3410" ref-type="fig">Fig. 4</xref>). The MDA, SOD, CAT and GSH-PX activities were improved by treatment with naringin (20, 40 and 80 mg/kg) (<xref rid="f4-etm-0-0-3410" ref-type="fig">Fig. 4</xref>).</p>
</sec>
<sec>
<title>Effect of naringin on STAT3 protein expression in AS mouse model</title>
<p>To elucidate the protective effect of naringin on STAT3, STAT3 protein expression of AS mouse was tested using a western blot assay. The STAT3 protein expression was induced in AS mouse (<xref rid="f5-etm-0-0-3410" ref-type="fig">Fig. 5</xref>). However, treatment with naringin (20, 40 and 80 mg/kg) mitigated this increased expression of STAT3 protein in AS mouse (<xref rid="f5-etm-0-0-3410" ref-type="fig">Fig. 5</xref>).</p>
</sec>
<sec>
<title>Protective effect of naringin on JAK2 protein expression in AS mouse model</title>
<p>To clarify the involvement the protective effect of naringin on JAK2, JAK2 protein expression of AS mouse was evaluated. The JAK2 protein expression was induced in AS mice; however, treatment with naringin (20, 40 and 80 mg/kg) decreased this enhanced JAK2 expression (<xref rid="f6-etm-0-0-3410" ref-type="fig">Fig. 6</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>AS is a chronic inflammatory disease, in which the rheumatoid factor is important, and it involves axial bone joints and tendon ligament attachment points, and the lesion is finally developed into the fibrosis of central joint and ankylosis, forming a typical &#x2018;bamboo vertebrae&#x2019; (<xref rid="b19-etm-0-0-3410" ref-type="bibr">19</xref>). The pathogenesis of AS is currently unclear; however, its occurrence is associated with heredity, chronic infections, autoimmune disorders and endocrine disorders. The joint changes of AS primarily include synovial thickening and infiltration of macrophages, lymphocytes and plasma cells, accompanied by joint fibrosis and bone ankylosis (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>). The primary site of the lesion is the region where the ligaments and joint capsule are attached, in which the inflammation leads to bone destruction, defects and replacement by connective tissue containing lymph and plasma cells; the filled and repaired cancellous bone develops ligament ossification in eroded bone surface (<xref rid="b21-etm-0-0-3410" ref-type="bibr">21</xref>).</p>
<p>The present study showed that administration of naringin increased OC and ALP activity, while reducing TG activity in AS model mice. These results are consistent with those of previous studies; for example, Liu <italic>et al</italic> suggested that the effects of naringin upregulates osteogenesis in human amniotic fluid-derived stem cells (<xref rid="b22-etm-0-0-3410" ref-type="bibr">22</xref>). Furthermore, Li <italic>et al</italic> reported that naringin is able to significantly improved ALP activity as well as upregulate the expression of type I collagen in the osteoblastic cell line MC3T3-E1 (<xref rid="b23-etm-0-0-3410" ref-type="bibr">23</xref>).</p>
<p>AS is a type of rheumatism characterized by chronic inflammation of the axial joint, and may involve the internal organs and other tissues (<xref rid="b24-etm-0-0-3410" ref-type="bibr">24</xref>). Most scholars believe that this disease is an autoimmune inflammation reaction caused predominantly by genetic factors, in addition to being stimulated by trauma, infection, fatigue and other environmental factors (<xref rid="b25-etm-0-0-3410" ref-type="bibr">25</xref>&#x2013;<xref rid="b27-etm-0-0-3410" ref-type="bibr">27</xref>). The present results showed that naringin attenuates NF-&#x03BA;B p65 unit, TNF-&#x03B1;, IL-1&#x03B2; and IL-6 activity in AS mice. These results are consistent with a previous study in which naringin was shown to ameliorate oxidative stress and inflammation in mice (<xref rid="b28-etm-0-0-3410" ref-type="bibr">28</xref>). In addition, it has been suggested that naringin may exert anti-inflammatory effects in the adult brain (<xref rid="b29-etm-0-0-3410" ref-type="bibr">29</xref>). However, the detailed mechanisms underlying the anti-inflammatory effects of naringin in AS mouse remain unclear, and further clarification is required in future.</p>
<p>In patients with AS, neutrophils are activated so that reactive oxygen species are generated, leading to oxidative stress (<xref rid="b9-etm-0-0-3410" ref-type="bibr">9</xref>). As a result of the increase in myeloperoxidase activity and advanced oxidation protein products in patients, the sulfhydryl level is decreased, from which it may be inferred that activated neutrophils serve a crucial function in the pathogenesis of AS (<xref rid="b30-etm-0-0-3410" ref-type="bibr">30</xref>). In the blood of patients with active AS, MDA levels and catalase activity are increased compared with those in control group (<xref rid="b9-etm-0-0-3410" ref-type="bibr">9</xref>). This catalase activity is positively correlated with erythrocyte sedimentation rate and C-reactive protein levels, and it is believed that the increase of catalase activity is a response to increased superoxide anion (<xref rid="b31-etm-0-0-3410" ref-type="bibr">31</xref>). The present results indicated that naringin reduced the MDA activity and increased the SOD, CAT and GSH-PX activities of the AS mice. Chen <italic>et al</italic> indicated that naringin had effective protection against paraquat-induced acute lung injury and pulmonary fibrosis through increasing activities of SOD, GSH-PX in mice (<xref rid="b32-etm-0-0-3410" ref-type="bibr">32</xref>). Cui <italic>et al</italic> suggested that naringin benefited the recovery of traumatic brain injury by reducing oxidative and inflammatory alterations in mice (<xref rid="b33-etm-0-0-3410" ref-type="bibr">33</xref>).</p>
<p>STATs are a group of cytoplasmic protein transcription factors, mediating the cytoplasm, which play a key role in the signaling of the nucleus (<xref rid="b34-etm-0-0-3410" ref-type="bibr">34</xref>). It has been reported that mutant mice lacking STAT3 are highly sensitive to AS, and the concentrations of serum inflammatory cytokines such as TNF-&#x03B1;, IL-1&#x03B2; and IL-6 are increased (<xref rid="b35-etm-0-0-3410" ref-type="bibr">35</xref>). Furthermore, macrophages lacking in STAT3 show abnormal activation phenotypes, such as increased production of inflammatory cytokines in response to endotoxin (<xref rid="b36-etm-0-0-3410" ref-type="bibr">36</xref>). STAT3 activation is crucial for the prevention of chronic inflammation in mice (<xref rid="b37-etm-0-0-3410" ref-type="bibr">37</xref>). The present results showed that naringin inhibited the STAT3 protein expression in AS rat. A previous study showed that naringin inhibited the development of carrageenan-induced acute lung inflammation via suppression of STAT3 (<xref rid="b38-etm-0-0-3410" ref-type="bibr">38</xref>).</p>
<p>AK2 belongs to Janus kinase family, and the gene is located in the short arm of chromosome 9 (9p24), belonging to JAK family together with JAK1, JAK3 and TYK2 as intracellular protein tyrosine kinase (<xref rid="b39-etm-0-0-3410" ref-type="bibr">39</xref>). Under normal physiological conditions, JAK2 mediates the signal transduction of a variety of cytokines, including erythropoietin, thrombopoietin, granulocyte-macrophage colony stimulating factor and IL-3, thus regulating and promoting cell proliferation (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>). The present study showed that naringin also inhibited JAK2 protein expression in AS rat. In addition, naringin appeared to exert an anti-inflammatory effect via the suppression of the JAK2/STAT3 signaling pathway.</p>
<p>In summary, naringin exerted notable osteogenic, anti-inflammatory and anti-oxidative effects, and the mechanism was mediated by the downregulation of the JAK2/STAT3 signaling pathways in AS mice. Future studies are required to investigate the protective effect of naringin against AS.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-etm-0-0-3410"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YF</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Tu</surname><given-names>SH</given-names></name><name><surname>Zheng</surname><given-names>CH</given-names></name><name><surname>Liu</surname><given-names>PL</given-names></name><name><surname>Hu</surname><given-names>YH</given-names></name></person-group><article-title>Etanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis</article-title><source>Exp Ther Med</source><volume>8</volume><fpage>1585</fpage><lpage>1592</lpage><year>2014</year><pub-id pub-id-type="pmid">25289064</pub-id></element-citation></ref>
<ref id="b2-etm-0-0-3410"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>CT</given-names></name><name><surname>Huo</surname><given-names>AP</given-names></name><name><surname>Chang</surname><given-names>HN</given-names></name><name><surname>Tsai</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>WS</given-names></name><name><surname>Wang</surname><given-names>HP</given-names></name></person-group><article-title>Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives</article-title><source>Arch Med Res</source><volume>38</volume><fpage>190</fpage><lpage>195</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.arcmed.2006.09.008</pub-id><pub-id pub-id-type="pmid">17227728</pub-id></element-citation></ref>
<ref id="b3-etm-0-0-3410"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Decreased programmed death-1 expression on the T cells of patients with ankylosing spondylitis</article-title><source>Am J Med Sci</source><volume>349</volume><fpage>488</fpage><lpage>492</lpage><year>2015</year><pub-id pub-id-type="doi">10.1097/MAJ.0000000000000468</pub-id><pub-id pub-id-type="pmid">25881983</pub-id></element-citation></ref>
<ref id="b4-etm-0-0-3410"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rednic</surname><given-names>S</given-names></name><name><surname>Marinescu</surname><given-names>C</given-names></name><name><surname>Chira</surname><given-names>R</given-names></name><name><surname>Rogojan</surname><given-names>L</given-names></name><name><surname>Rednic</surname><given-names>N</given-names></name></person-group><article-title>Treatment with infliximab in a patient with ankylosing spondylitis and Crohn&#x0027;s disease</article-title><source>J Gastrointestin Liver Dis</source><volume>15</volume><fpage>379</fpage><lpage>382</lpage><year>2006</year><pub-id pub-id-type="pmid">17205151</pub-id></element-citation></ref>
<ref id="b5-etm-0-0-3410"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mielants</surname><given-names>H</given-names></name><name><surname>Veys</surname><given-names>EM</given-names></name><name><surname>Cuvelier</surname><given-names>C</given-names></name><etal/></person-group><article-title>Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy&#x2013;&#x2013;a prospective study</article-title><source>J Rheumatol</source><volume>20</volume><fpage>1567</fpage><lpage>1572</lpage><year>1993</year><pub-id pub-id-type="pmid">8164217</pub-id></element-citation></ref>
<ref id="b6-etm-0-0-3410"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>U</given-names></name><name><surname>Hodler</surname><given-names>J</given-names></name><name><surname>Kubik</surname><given-names>RA</given-names></name><name><surname>Rufibach</surname><given-names>K</given-names></name><name><surname>Lambert</surname><given-names>RG</given-names></name><name><surname>Kissling</surname><given-names>RO</given-names></name><name><surname>Pfirrmann</surname><given-names>CW</given-names></name><name><surname>Maksymowych</surname><given-names>WP</given-names></name></person-group><article-title>Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain</article-title><source>Arthritis Rheum</source><volume>61</volume><fpage>900</fpage><lpage>908</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/art.24507</pub-id><pub-id pub-id-type="pmid">19565558</pub-id></element-citation></ref>
<ref id="b7-etm-0-0-3410"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maksymowych</surname><given-names>WP</given-names></name><name><surname>Chiowchanwisawakit</surname><given-names>P</given-names></name><name><surname>Clare</surname><given-names>T</given-names></name><name><surname>Pedersen</surname><given-names>SJ</given-names></name><name><surname>&#x00D8;stergaard</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>RG</given-names></name></person-group><article-title>Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: Evidence of a relationship between inflammation and new bone formation</article-title><source>Arthritis Rheum</source><volume>60</volume><fpage>93</fpage><lpage>102</lpage><year>2009</year><pub-id pub-id-type="doi">10.1002/art.24132</pub-id><pub-id pub-id-type="pmid">19116919</pub-id></element-citation></ref>
<ref id="b8-etm-0-0-3410"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okano</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Tsuchiya</surname><given-names>K</given-names></name><name><surname>Akiba</surname><given-names>T</given-names></name><name><surname>Nitta</surname><given-names>K</given-names></name></person-group><article-title>Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy</article-title><source>Int J Clin Exp Med</source><volume>8</volume><fpage>20959</fpage><lpage>20964</lpage><year>2015</year><pub-id pub-id-type="pmid">26885025</pub-id></element-citation></ref>
<ref id="b9-etm-0-0-3410"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozaci</surname><given-names>LD</given-names></name><name><surname>Sari</surname><given-names>I</given-names></name><name><surname>Alacacioglu</surname><given-names>A</given-names></name><name><surname>Akar</surname><given-names>S</given-names></name><name><surname>Akkoc</surname><given-names>N</given-names></name></person-group><article-title>Evaluation of inflammation and oxidative stress in ankylosing spondylitis: A role for macrophage migration inhibitory factor</article-title><source>Mod Rheumatol</source><volume>20</volume><fpage>34</fpage><lpage>39</lpage><year>2010</year><pub-id pub-id-type="doi">10.3109/s10165-009-0230-9</pub-id><pub-id pub-id-type="pmid">19787418</pub-id></element-citation></ref>
<ref id="b10-etm-0-0-3410"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagetia</surname><given-names>GC</given-names></name><name><surname>Reddy</surname><given-names>TK</given-names></name><name><surname>Venkatesha</surname><given-names>VA</given-names></name><name><surname>Kedlaya</surname><given-names>R</given-names></name></person-group><article-title>Influence of naringin on ferric iron induced oxidative damage in vitro</article-title><source>Clin Chim Acta</source><volume>347</volume><fpage>189</fpage><lpage>197</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.cccn.2004.04.022</pub-id><pub-id pub-id-type="pmid">15313158</pub-id></element-citation></ref>
<ref id="b11-etm-0-0-3410"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name></person-group><article-title>Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model</article-title><source>J Orthop Res</source><volume>28</volume><fpage>451</fpage><lpage>456</lpage><year>2010</year><pub-id pub-id-type="pmid">19824055</pub-id></element-citation></ref>
<ref id="b12-etm-0-0-3410"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><name><surname>Jeon</surname><given-names>SM</given-names></name><name><surname>Do</surname><given-names>GM</given-names></name><name><surname>Kwon</surname><given-names>EY</given-names></name><name><surname>Cho</surname><given-names>YY</given-names></name><name><surname>Kim</surname><given-names>DJ</given-names></name><name><surname>Jeong</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>YB</given-names></name><etal/></person-group><article-title>Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet</article-title><source>J Med Food</source><volume>9</volume><fpage>582</fpage><lpage>586</lpage><year>2006</year><pub-id pub-id-type="doi">10.1089/jmf.2006.9.582</pub-id><pub-id pub-id-type="pmid">17201649</pub-id></element-citation></ref>
<ref id="b13-etm-0-0-3410"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Jeong</surname><given-names>TS</given-names></name><name><surname>Bok</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>YB</given-names></name></person-group><article-title>Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits</article-title><source>J Cardiovasc Pharmacol</source><volume>38</volume><fpage>947</fpage><lpage>955</lpage><year>2001</year><pub-id pub-id-type="doi">10.1097/00005344-200112000-00017</pub-id><pub-id pub-id-type="pmid">11707699</pub-id></element-citation></ref>
<ref id="b14-etm-0-0-3410"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>SP</given-names></name><name><surname>Nguyen</surname><given-names>M</given-names></name><name><surname>Yow</surname><given-names>TT</given-names></name><name><surname>Chu</surname><given-names>C</given-names></name><name><surname>Johnston</surname><given-names>GA</given-names></name><name><surname>Hanrahan</surname><given-names>JR</given-names></name><name><surname>Chebib</surname><given-names>M</given-names></name></person-group><article-title>The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice</article-title><source>Neurochem Res</source><volume>34</volume><fpage>1867</fpage><lpage>1875</lpage><year>2009</year><pub-id pub-id-type="doi">10.1007/s11064-009-9969-9</pub-id><pub-id pub-id-type="pmid">19387830</pub-id></element-citation></ref>
<ref id="b15-etm-0-0-3410"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camargo</surname><given-names>CA</given-names></name><name><surname>Gomes-Marcondes</surname><given-names>MC</given-names></name><name><surname>Wutzki</surname><given-names>NC</given-names></name><name><surname>Aoyama</surname><given-names>H</given-names></name></person-group><article-title>Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor alpha levels in rats with Walker 256 carcinosarcoma</article-title><source>Anticancer Res</source><volume>32</volume><fpage>129</fpage><lpage>133</lpage><year>2012</year><pub-id pub-id-type="pmid">22213297</pub-id></element-citation></ref>
<ref id="b16-etm-0-0-3410"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>M</given-names></name></person-group><article-title>Cell surface engineering of &#x03B1;-l-rhamnosidase for naringin hydrolysis</article-title><source>Bioresour Technol</source><volume>123</volume><fpage>144</fpage><lpage>149</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.biortech.2012.05.083</pub-id><pub-id pub-id-type="pmid">22940311</pub-id></element-citation></ref>
<ref id="b17-etm-0-0-3410"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>P</given-names></name></person-group><article-title>Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice</article-title><source>Biomed Res Int</source><volume>2013</volume><fpage>171573</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/171573</pub-id><pub-id pub-id-type="pmid">24324956</pub-id></element-citation></ref>
<ref id="b18-etm-0-0-3410"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>VS</given-names></name><name><surname>Rajmane</surname><given-names>AR</given-names></name><name><surname>Adil</surname><given-names>M</given-names></name><name><surname>Kandhare</surname><given-names>AD</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Bodhankar</surname><given-names>SL</given-names></name></person-group><article-title>Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats</article-title><source>J Biomed Res</source><volume>28</volume><fpage>132</fpage><lpage>145</lpage><year>2014</year><pub-id pub-id-type="pmid">24683411</pub-id></element-citation></ref>
<ref id="b19-etm-0-0-3410"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiau</surname><given-names>MY</given-names></name><name><surname>Lo</surname><given-names>MK</given-names></name><name><surname>Chang</surname><given-names>CP</given-names></name><name><surname>Yang</surname><given-names>TP</given-names></name><name><surname>Ho</surname><given-names>KT</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name></person-group><article-title>Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan</article-title><source>Ann Rheum Dis</source><volume>66</volume><fpage>562</fpage><lpage>563</lpage><year>2007</year><pub-id pub-id-type="doi">10.1136/ard.2006.065888</pub-id><pub-id pub-id-type="pmid">17360787</pub-id></element-citation></ref>
<ref id="b20-etm-0-0-3410"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>LS</given-names></name><name><surname>Chan</surname><given-names>KY</given-names></name><name><surname>Li</surname><given-names>EK</given-names></name></person-group><article-title>The influence of illness and variables associated with functional limitations in Chinese patients with ankylosing spondylitis</article-title><source>J Rheumatol</source><volume>34</volume><fpage>1032</fpage><lpage>1039</lpage><year>2007</year><pub-id pub-id-type="pmid">17343322</pub-id></element-citation></ref>
<ref id="b21-etm-0-0-3410"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>P</given-names></name></person-group><article-title>Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice</article-title><source>Biomed Res Int</source><volume>2013</volume><fpage>171573</fpage><year>2013</year><pub-id pub-id-type="doi">10.1155/2013/171573</pub-id><pub-id pub-id-type="pmid">24324956</pub-id></element-citation></ref>
<ref id="b22-etm-0-0-3410"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>ST</given-names></name></person-group><article-title>Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells</article-title><source>J Tissue Eng Regen Med</source><year>2014</year><comment>(Epub ahead of print)</comment><pub-id pub-id-type="doi">10.1002/term.1911</pub-id></element-citation></ref>
<ref id="b23-etm-0-0-3410"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name></person-group><article-title>Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3T3-E1</article-title><source>Phytomedicine</source><volume>18</volume><fpage>985</fpage><lpage>989</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.phymed.2011.03.002</pub-id><pub-id pub-id-type="pmid">21741227</pub-id></element-citation></ref>
<ref id="b24-etm-0-0-3410"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>U</given-names></name><name><surname>Teichmann</surname><given-names>J</given-names></name><name><surname>Stracke</surname><given-names>H</given-names></name></person-group><article-title>Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity and clinical manifestations in ankylosing spondylitis</article-title><source>Eur J Med Res</source><volume>5</volume><fpage>507</fpage><lpage>511</lpage><year>2000</year><pub-id pub-id-type="pmid">11147993</pub-id></element-citation></ref>
<ref id="b25-etm-0-0-3410"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>M</given-names></name><name><surname>Dotzlaw</surname><given-names>H</given-names></name><name><surname>Neeck</surname><given-names>G</given-names></name></person-group><article-title>Ankylosing spondylitis and rheumatoid arthritis: serum levels of TNF-alpha and Its soluble receptors during the course of therapy with etanercept and infliximab</article-title><source>Biomed Res Int</source><volume>2014</volume><fpage>675108</fpage><year>2014</year><pub-id pub-id-type="doi">10.1155/2014/675108</pub-id><pub-id pub-id-type="pmid">24783218</pub-id></element-citation></ref>
<ref id="b26-etm-0-0-3410"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WN</given-names></name><name><surname>Tso</surname><given-names>TK</given-names></name><name><surname>Kuo</surname><given-names>YC</given-names></name><name><surname>Tsay</surname><given-names>GJ</given-names></name></person-group><article-title>Distinct impacts of syndesmophyte formation on male and female patients with ankylosing spondylitis</article-title><source>Int J Rheum Dis</source><volume>15</volume><fpage>163</fpage><lpage>168</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1756-185X.2011.01687.x</pub-id><pub-id pub-id-type="pmid">22462419</pub-id></element-citation></ref>
<ref id="b27-etm-0-0-3410"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Shao</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>Melatonin synergized with cyclosporine A improves cardiac allograft survival by suppressing inflammation and apoptosis</article-title><source>Mol Med Rep</source><volume>10</volume><fpage>1323</fpage><lpage>1328</lpage><year>2014</year><pub-id pub-id-type="pmid">25059226</pub-id></element-citation></ref>
<ref id="b28-etm-0-0-3410"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golechha</surname><given-names>M</given-names></name><name><surname>Sarangal</surname><given-names>V</given-names></name><name><surname>Bhatia</surname><given-names>J</given-names></name><name><surname>Chaudhry</surname><given-names>U</given-names></name><name><surname>Saluja</surname><given-names>D</given-names></name><name><surname>Arya</surname><given-names>DS</given-names></name></person-group><article-title>Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: Possible mechanisms of neuroprotection</article-title><source>Epilepsy Behav</source><volume>41</volume><fpage>98</fpage><lpage>102</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.yebeh.2014.09.058</pub-id><pub-id pub-id-type="pmid">25461197</pub-id></element-citation></ref>
<ref id="b29-etm-0-0-3410"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>UJ</given-names></name><name><surname>Kim</surname><given-names>SR</given-names></name></person-group><article-title>Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain</article-title><source>Neural Regen Res</source><volume>9</volume><fpage>1514</fpage><lpage>1517</lpage><year>2014</year><pub-id pub-id-type="doi">10.4103/1673-5374.139476</pub-id><pub-id pub-id-type="pmid">25317167</pub-id></element-citation></ref>
<ref id="b30-etm-0-0-3410"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feijoo</surname><given-names>M</given-names></name><name><surname>Tunez</surname><given-names>I</given-names></name><name><surname>Tasset</surname><given-names>I</given-names></name><name><surname>Montilla</surname><given-names>P</given-names></name><name><surname>Ruiz</surname><given-names>A</given-names></name><name><surname>Collantes</surname><given-names>E</given-names></name></person-group><article-title>Infliximab reduces oxidative stress in ankylosing spondylitis</article-title><source>Clin Exp Rheumatol</source><volume>27</volume><fpage>167</fpage><lpage>168</lpage><year>2009</year><pub-id pub-id-type="pmid">19327250</pub-id></element-citation></ref>
<ref id="b31-etm-0-0-3410"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karakoc</surname><given-names>M</given-names></name><name><surname>Altindag</surname><given-names>O</given-names></name><name><surname>Keles</surname><given-names>H</given-names></name><name><surname>Soran</surname><given-names>N</given-names></name><name><surname>Selek</surname><given-names>S</given-names></name></person-group><article-title>Serum oxidative-antioxidative status in patients with ankylosing spondilitis</article-title><source>Rheumatol Int</source><volume>27</volume><fpage>1131</fpage><lpage>1134</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/s00296-007-0352-3</pub-id><pub-id pub-id-type="pmid">17443328</pub-id></element-citation></ref>
<ref id="b32-etm-0-0-3410"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Nie</surname><given-names>YC</given-names></name><name><surname>Luo</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>YF</given-names></name><name><surname>Cheng</surname><given-names>GH</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>KJ</given-names></name><name><surname>Su</surname><given-names>WW</given-names></name><name><surname>Shen</surname><given-names>JG</given-names></name><name><surname>Li</surname><given-names>PB</given-names></name></person-group><article-title>Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice</article-title><source>Food Chem Toxicol</source><volume>58</volume><fpage>133</fpage><lpage>140</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.fct.2013.04.024</pub-id><pub-id pub-id-type="pmid">23603004</pub-id></element-citation></ref>
<ref id="b33-etm-0-0-3410"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>QJ</given-names></name><name><surname>Wang</surname><given-names>LY</given-names></name><name><surname>Wei</surname><given-names>ZX</given-names></name><name><surname>Qu</surname><given-names>WS</given-names></name></person-group><article-title>Continual naringin treatment benefits the recovery of traumatic brain injury in rats through reducing oxidative and inflammatory alterations</article-title><source>Neurochem Res</source><volume>39</volume><fpage>1254</fpage><lpage>1262</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s11064-014-1306-2</pub-id><pub-id pub-id-type="pmid">24728904</pub-id></element-citation></ref>
<ref id="b34-etm-0-0-3410"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kicinska</surname><given-names>A</given-names></name><name><surname>Leluk</surname><given-names>J</given-names></name><name><surname>Jarmuszkiewicz</surname><given-names>W</given-names></name></person-group><article-title>Acanthamoeba castellanii STAT protein</article-title><source>PLoS One</source><volume>9</volume><fpage>e111345</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.pone.0111345</pub-id><pub-id pub-id-type="pmid">25338074</pub-id></element-citation></ref>
<ref id="b35-etm-0-0-3410"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danoy</surname><given-names>P</given-names></name><name><surname>Pryce</surname><given-names>K</given-names></name><name><surname>Hadler</surname><given-names>J</given-names></name><name><surname>Bradbury</surname><given-names>LA</given-names></name><name><surname>Farrar</surname><given-names>C</given-names></name><name><surname>Pointon</surname><given-names>J</given-names></name></person-group><article-title>Australo-Anglo-American Spondyloarthritis Consortium, Ward M, Weisman M, Reveille JD, et al: Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn&#x0027;s disease</article-title><source>PLoS Genet</source><volume>6</volume><fpage>e1001195</fpage><year>2010</year><pub-id pub-id-type="doi">10.1371/journal.pgen.1001195</pub-id><pub-id pub-id-type="pmid">21152001</pub-id></element-citation></ref>
<ref id="b36-etm-0-0-3410"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>SF</given-names></name><name><surname>Attia</surname><given-names>SM</given-names></name><name><surname>Bakheet</surname><given-names>SA</given-names></name><name><surname>Zoheir</surname><given-names>KM</given-names></name><name><surname>Ansari</surname><given-names>MA</given-names></name><name><surname>Korashy</surname><given-names>HM</given-names></name><name><surname>Abdel-Hamied</surname><given-names>HE</given-names></name><name><surname>Ashour</surname><given-names>AE</given-names></name><name><surname>Abd-Allah</surname><given-names>AR</given-names></name></person-group><article-title>Naringin attenuates the development of carrageenan-induced acute lung inflammation through inhibition of NF-&#x03BA;b, STAT3 and pro-inflammatory mediators and enhancement of I&#x03BA;B&#x03B1; and anti-inflammatory cytokines</article-title><source>Inflammation</source><volume>38</volume><fpage>846</fpage><lpage>857</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s10753-014-9994-y</pub-id><pub-id pub-id-type="pmid">25117567</pub-id></element-citation></ref>
<ref id="b37-etm-0-0-3410"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>SI</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Danoy</surname><given-names>PA</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Thomas</surname><given-names>GP</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><etal/></person-group><article-title>Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese</article-title><source>Ann Rheum Dis</source><volume>70</volume><fpage>289</fpage><lpage>292</lpage><year>2011</year><pub-id pub-id-type="doi">10.1136/ard.2010.133322</pub-id><pub-id pub-id-type="pmid">21068102</pub-id></element-citation></ref>
<ref id="b38-etm-0-0-3410"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmers</surname><given-names>TA</given-names></name><name><surname>Fishel</surname><given-names>ML</given-names></name><name><surname>Bonetto</surname><given-names>A</given-names></name></person-group><article-title>STAT3 in the Systemic Inflammation of Cancer Cachexia</article-title><source>Semin Cell Dev Biol</source><year>2016</year><pub-id pub-id-type="doi">10.1016/j.semcdb.2016.02.009</pub-id><pub-id pub-id-type="pmid">26860754</pub-id></element-citation></ref>
<ref id="b39-etm-0-0-3410"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han population</article-title><source>Clin Immunol</source><volume>136</volume><fpage>442</fpage><lpage>446</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.clim.2010.05.003</pub-id><pub-id pub-id-type="pmid">20627814</pub-id></element-citation></ref>
<ref id="b40-etm-0-0-3410"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Improvement of thoracic aortic vasoreactivity by continuous and intermittent exercise in high-fat diet-induced obese rats</article-title><source>Biomed Rep</source><volume>3</volume><fpage>527</fpage><lpage>532</lpage><year>2015</year><pub-id pub-id-type="pmid">26171160</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-etm-0-0-3410" position="float">
<label>Figure 1.</label>
<caption><p>Chemical structure of naringin.</p></caption>
<graphic xlink:href="etm-12-02-1153-g00.tif"/>
</fig>
<fig id="f2-etm-0-0-3410" position="float">
<label>Figure 2.</label>
<caption><p>Effect of naringin on OC, ALP and TG activity values in AS mouse model. The protective effect of naringin on (A) OC, (B) ALP and (C) TG activity values in the AS mouse model. <sup>##</sup>P&#x003C;0.01 vs. control group; &#x002A;P&#x003C;0.05 vs. AS group; &#x002A;&#x002A;P&#x003C;0.01 vs. AS group. OC, osteocalcin; AS, ankylosing spondylitis group; Nar (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>), naringin (20 mg/kg)-treated; Nar (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>), naringin (40 mg/kg)-treated; Nar (80), naringin (80 mg/kg)-treated; One-way analysis of variance was performed for the statistical analysis of data, the Student&#x0027;s t-test was used to analyze statistical significance. ALP, alkaline phosphatase; TG, triglyceride.</p></caption>
<graphic xlink:href="etm-12-02-1153-g01.jpg"/>
</fig>
<fig id="f3-etm-0-0-3410" position="float">
<label>Figure 3.</label>
<caption><p>Effect of naringin on inflammatory factors in AS mouse model. The protective effect of naringin on the activity (A) NF-&#x03BA;B p65 unit, (B) TNF-&#x03B1;, (C) IL-1&#x03B2; and (D) IL-6 values in the AS mouse model. <sup>##</sup>P&#x003C;0.01 vs. control group; &#x002A;P&#x003C;0.05 vs. AS group; &#x002A;&#x002A;P&#x003C;0.01 vs. AS group. NF-&#x03BA;B p65, nuclear factor-&#x03BA;B p65; AS, ankylosing spondylitis group; Nar (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>), naringin (20 mg/kg)-treated; Nar (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>), naringin (40 mg/kg)-treated; Nar (80), naringin (80 mg/kg)-treated; One way analysis of variance was performed for the statistical analysis of data, the Student&#x0027;s t-test was used to analyze statistical significance. TNF-&#x03B1;, tumor necrosis factor-&#x03B1;; IL, interleukin.</p></caption>
<graphic xlink:href="etm-12-02-1153-g02.jpg"/>
</fig>
<fig id="f4-etm-0-0-3410" position="float">
<label>Figure 4.</label>
<caption><p>Effect of naringin on oxidative stress markers in AS mouse model. The protective effect of naringin on the concentrations of (A) MDA, (B) SOD, (C) CAT and (D) GSH-PX in the AS mouse model. <sup>##</sup>P&#x003C;0.01 vs. control group; &#x002A;P&#x003C;0.05 vs. AS group; &#x002A;&#x002A;P&#x003C;0.01 vs. AS group. MDA, malondialdehyde; AS, ankylosing spondylitis group; Nar (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>), naringin (20 mg/kg)-treated; Nar (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>), naringin (40 mg/kg)-treated; Nar (80), naringin (80 mg/kg)-treated; One way analysis of variance was performed for the statistical analysis of data, the Student&#x0027;s t-test was used to analyze statistical significance. SOD, superoxide dismutase; CAT, catalase; GSH-PX, glutathione peroxidase.</p></caption>
<graphic xlink:href="etm-12-02-1153-g03.jpg"/>
</fig>
<fig id="f5-etm-0-0-3410" position="float">
<label>Figure 5.</label>
<caption><p>Effect of naringin on STAT3 protein expression in AS mouse model. (A) Western blot assay showing STAT3 protein expression and (B) statistical analysis of STAT3 protein expression in the AS mouse model. <sup>##</sup>P&#x003C;0.01 vs. control group; &#x002A;P&#x003C;0.05 vs. AS group; &#x002A;&#x002A;P&#x003C;0.01 vs. AS group. STAT3, signal transducer and activator of transcription 3; AS, ankylosing spondylitis group; Nar (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>), naringin (20 mg/kg)-treated; Nar (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>), naringin (40 mg/kg)-treated; Nar (80), naringin (80 mg/kg)-treated. One-way analysis of variance was performed for the statistical analysis of data, the Student&#x0027;s t-test was used to analyze statistical significance.</p></caption>
<graphic xlink:href="etm-12-02-1153-g04.jpg"/>
</fig>
<fig id="f6-etm-0-0-3410" position="float">
<label>Figure 6.</label>
<caption><p>Effect of naringin on JAK2 protein expression in AS mouse model. (A) Western blot assay showing JAK2 protein expression and (B) statistical analysis of JAK2 protein expression in the AS mouse model. <sup>##</sup>P&#x003C;0.01 vs. control group; &#x002A;P&#x003C;0.05 vs. AS group; &#x002A;&#x002A;P&#x003C;0.01 vs. AS group. JAK2, Janus kinase 2; AS, ankylosing spondylitis group; Nar (<xref rid="b20-etm-0-0-3410" ref-type="bibr">20</xref>), naringin (20 mg/kg)-treated; Nar (<xref rid="b40-etm-0-0-3410" ref-type="bibr">40</xref>), naringin (40 mg/kg)-treated; Nar (80), naringin (80 mg/kg)-treated. One-way analysis of variance was performed for the statistical analysis of data, the Student&#x0027;s t-test was used to analyze statistical significance.</p></caption>
<graphic xlink:href="etm-12-02-1153-g05.jpg"/>
</fig>
</floats-group>
</article>
